why choose us

First received: July 05, 2023

Clinical Trial: Department of Defense PTSD Adaptive Platform Trial Intervention A - Fluoxetine

Study Status: Completed

Recruit Status: RECRUITING

Condition: Post Traumatic Stress Disorder

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multi-center, Multi-arm, Randomized, Placebo-controlled, Double-blind, Adaptive Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Potential Pharmacotherapeutic Interventi

Brief Summary: This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PTSD utilizing an adaptive platform trial design.Intervention A - Fluoxetine will assess the safety and efficacy of fluoxetine in participants with PTSD.Please see NCT05422612 for information on the S-21-02 Master Protocol.

Read more